0001209191-21-017475.txt : 20210303
0001209191-21-017475.hdr.sgml : 20210303
20210303201621
ACCESSION NUMBER: 0001209191-21-017475
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210301
FILED AS OF DATE: 20210303
DATE AS OF CHANGE: 20210303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FEES JESSICA
CENTRAL INDEX KEY: 0001760391
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38459
FILM NUMBER: 21711929
MAIL ADDRESS:
STREET 1: C/O SURFACE ONCOLOGY, ICN.
STREET 2: 50 HAMPSHIRE STREET 8TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Surface Oncology, Inc.
CENTRAL INDEX KEY: 0001718108
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 HAMPSHIRE STREET, 8TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-714-4096
MAIL ADDRESS:
STREET 1: 50 HAMPSHIRE STREET, 8TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-03-01
0
0001718108
Surface Oncology, Inc.
SURF
0001760391
FEES JESSICA
C/O SURFACE ONCOLOGY, INC.
50 HAMPSHIRE STREET, 8TH FLOOR
CAMBRIDGE
MA
02139
0
1
0
0
See Remarks
Stock Option (Right to Buy)
9.02
2021-03-01
4
A
0
68000
0.00
A
2031-03-01
Common Stock
68000
68000
D
This option shall become exercisable in equal monthly installments over four years following February 9, 2021, so long as the reporting person remains an employee or other service provider of the Company on such dates.
Title: Principal Accounting Officer, Principal Financial Officer
/s/ Jessica Fees
2021-03-03